News
Click claims FDA okay for first-in-class schizophrenia DTx
Click Therapeutics has won the first-ever FDA approval for a treatment for the negative symptoms of schizophrenia, a DTx called Motivista.
News
UK backs all health AI proposals in commission report
The UK will accept all 44 proposals made in a recent report on using AI tools in the NHS, including continuous monitoring after deployment.
Market Access
Beyond Market Access: Why healthcare-system understanding is...
Healthcare-system literacy, and the ability to contribute to system shaping, must become part of how healthcare leaders make decisions.
News
Lilly's BTK drug Jaypirca joins first-line options in US
Lilly's noncovalent BTK inhibitor Jaypirca has been cleared by the FDA for its first frontline indication, but will it be reserved for later-line use?
News
Novo faces delay in US review of haemophilia drug
The FDA has extended its review of Novo's experimental haemophilia A drug denecimig because of ongoing remediation work at a manufacturing facility.
News
Press Releases
Views & Analysis
Editor's Picks
Editor's Picks
